Gates Simon, Ealing Elizabeth
Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
BMJ Open. 2019 Sep 8;9(9):e024785. doi: 10.1136/bmjopen-2018-024785.
To describe and summarise how the results of randomised controlled trials (RCTs) that did not find a significant treatment effect are reported, and to estimate how commonly trial reports make unwarranted claims.
We performed a retrospective survey of published RCTs, published in four high impact factor general medical journals between June 2016 and June 2017.
Trials conducted in all settings were included.
94 reports of RCTs that did not find a difference in their main comparison or comparisons were included.
All interventions.
We recorded the way the results of each trial for its primary outcome or outcomes were described in Results and Conclusions sections of the Abstract, using a 10-category classification. Other outcomes were whether confidence intervals (CIs) and p values were presented for the main treatment comparisons, and whether the results and conclusions referred to measures of uncertainty. We estimated the proportion of papers that made claims that were not justified by the results, or were open to multiple interpretations.
94 trial reports (120 treatment comparisons) were included. In Results sections, for 58/120 comparisons (48.3%) the results of the study were re-stated, without interpretation, and 38/120 (31.7%) stated that there was no statistically significant difference. In Conclusions, 65/120 treatment comparisons (54.2%) stated that there was no treatment benefit, 14/120 (11.7%) that there was no significant benefit and 16/120 (13.3%) that there was no significant difference. CIs and p values were both presented by 84% of studies (79/94), but only 3/94 studies referred to uncertainty when drawing conclusions.
The majority of trials (54.2%) inappropriately interpreted a result that was not statistically significant as indicating no treatment benefit. Very few studies interpreted the result as indicating a lack of evidence against the null hypothesis of zero difference between the trial arms.
描述并总结未发现显著治疗效果的随机对照试验(RCT)结果是如何报告的,并估计试验报告中无端声称的情况有多常见。
我们对2016年6月至2017年6月期间在四种高影响因子综合医学期刊上发表的已发表RCT进行了回顾性调查。
纳入所有环境中进行的试验。
纳入94篇未在主要比较中发现差异的RCT报告。
所有干预措施。
我们使用10类分类法记录了每项试验主要结果在摘要的结果和结论部分中的描述方式。其他结果包括主要治疗比较是否给出了置信区间(CI)和p值,以及结果和结论是否提及不确定性度量。我们估计了做出的声称未得到结果证实或有多种解释的论文比例。
纳入94篇试验报告(120次治疗比较)。在结果部分,120次比较中有58次(48.3%)只是重述了研究结果,没有进行解释,38次(31.7%)指出没有统计学上的显著差异。在结论部分,120次治疗比较中有65次(54.2%)指出没有治疗益处,14次(11.7%)指出没有显著益处,16次(13.3%)指出没有显著差异。84%的研究(79/94)同时给出了CI和p值,但只有3/94的研究在得出结论时提及了不确定性。
大多数试验(54.2%)将无统计学显著性的结果错误地解释为表明没有治疗益处。极少有研究将结果解释为表明缺乏反对试验组间零差异无效假设的证据。